Carbamazepine in the Prophylaxis of Mood Disorders
Authors:
- Christian BarnasCBChristian Barnas
- Carl MillerCMCarl Miller
- Josef SchwitzerJSJosef Schwitzer
- W. Wolfgang FleischhackerWFW. Wolfgang Fleischhacker
- 1 February 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 10 (1) , 39-41
Abstract
Alternatives to lithium are desirable in the prophylaxis of affective disorders, especially in patients who are intolerant of or do not respond to that drug. In the past few years the anticonvulsant carbamazepine has been in the foreground of discussion. Twenty-four patients with affective disorders (17 unipolar depressed, six bipolar, and one unipolar manic) were included in a comparative trial of lithium and carbamazepine; 12 had been pretreated with lithium without a satisfactory effect. All patients received carbamazepine (four received it in combination with lithium) over a mean time span of 20.2 months. Eighty percent of the patients improved with carbamazepine treatment. Side effects were infrequent.Keywords
This publication has 4 references indexed in Scilit:
- The Effect of Carbamazepine and Lithium on Remission from Affective IllnessThe British Journal of Psychiatry, 1987
- THE COMPARATIVE EFFICACY AND SAFETY OF CARBAMAZEPINE VERSUS LITHIUM - A RANDOMIZED, DOUBLE-BLIND 3-YEAR TRIAL IN 83 PATIENTS1986
- Long-Term Prophylactic Effects of Carbamazepine in Affective DisorderThe British Journal of Psychiatry, 1983
- A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illnessPsychopharmacology, 1981